By clicking “View Open Positions”, you acknowledge and consent to your personal information being transferred cross-border to Pivotal Headquarters in Hong Kong. For more details, please refer to the Recruitment Privacy Policy.

EN
  • 中文
  • EN
EN
  • 中文
  • EN

Genfleet

THERAPEUTIC AREA


Oncology, Immunology

 

 

YEAR INVESTED


2017

 

 

STAGE


Public

 

 

WEBSITE


www.genfleet.com 

 

 

 

GenFleet Therapeutics is dedicated to serving significant unmet medical needs globally in oncology and immunology. Leveraging its deep understanding of disease biology and translational medicine, GenFleet has established a proprietary and fully integrated R&D system that yields a robust pipeline of multiple cutting-edge products with novel mechanisms and global IP. Since its inception in 2017, GenFleet has built up industry-leading capabilities and expertise in developing novel drug candidates spanning small molecules and biologics. Its pipeline comprises numerous programs that have advanced to later-stage or pivotal clinical trials across China, the United States and Europe. 



图片展示

SHANGHAI

Suite 2001, YI FUNG PLACE

99 West Ziyun Road
Changning District
Shanghai 200051, China

HONG KONG

17th Floor

AIRSIDE

2 Concorde Road, Kai Tak

Hong Kong SAR

SAN FRANCISCO

501 2nd Street, Suite 200 

San Francisco, CA 94107 

United States

图片展示
图片展示
图片展示
图片展示

© 2025 Pivotal Life Sciences - All intellectual property rights reserved


添加微信好友,详细了解产品
使用企业微信
“扫一扫”加入群聊
复制成功
添加微信好友,详细了解产品
我知道了